• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    6/18/24 1:39:53 PM ET
    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Computer Software: Prepackaged Software
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $ALAR alert in real time by email

    Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.

    Quantum shares dipped 44.5% to $0.43 on Tuesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Reliance Global Group, Inc. (NASDAQ:RELI) shares jumped 350% to $1.00 after the company issued an update on the pending acquisition of Spetner Associates.
    • NLS Pharmaceutics AG (NASDAQ:NLSP) shares rose 166% to $0.3930 after jumping 30% on Monday.
    • Actelis Networks, Inc. (NASDAQ:ASNS) climbed 80.9% to $2.08 after the company announced a partnership with Carahsoft Technology Corp.
    • Comtech Telecommunications Corp. (NASDAQ:CMTL) rose 65% to $3.5801 after the company announced a new $222 million credit facility.
    • Mustang Bio, Inc. (NASDAQ:MBIO) gained 60.6% to $1.2050. Mustang Bio shares jumped 477% on Monday after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing an overall response rate of 90% with one patient remaining in complete remission at 31 months.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) climbed 39.2% to $0.2342 following fourth-quarter results.
    • Silk Road Medical, Inc (NASDAQ:SILK) jumped 23.8% to $26.83 after the company entered a definitive deal to be acquired by Boston Scientific for $27.50 per share.
    • Mesa Air Group, Inc. (NASDAQ:MESA) gained 23.7% to $1.3990 following upbeat quarterly earnings.
    • Silynxcom Ltd. (NASDAQ:SYNX) gained 20.4% to $3.8826 as the company secured multiple orders from the  US Federal and Law Enforcement Organizations of its new tactical system.
    • La-Z-Boy Incorporated (NYSE:LZB) jumped 17.7% to $40.11.
    • Karooooo Ltd. (NASDAQ:KARO) gained 14.6% to $33.59
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares rose 14.5% to $0.2049 following better-than-expected fourth-quarter earnings.
    • Chegg, Inc. (NYSE:CHGG) rose 14.2% to $2.9811 after the company announced a restructuring plan and new vision for growth.
    • Mynd.ai, Inc. (NASDAQ:MYND) gained 9.7% to $2.7183.
    • Patterson Companies, Inc. (NASDAQ:PDCO) gained 9.7% to $25.06 following quarterly results.
    • Chewy, Inc. (NYSE:CHWY) climbed 9.4% to $24.96
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) rose 9% to $4.7305 after signing a 10-launch deal with Japanese firm Synspective in Tokyo.
    • Toast, Inc. (NYSE:TOST) gained 8.7% to $24.57.
    • e.l.f. Beauty, Inc. (NYSE:ELF) rose 7% to $209.00 after Canaccord Genuity maintained a Buy rating and raised its price target from $214 to $250.

    Losers

    • Solidion Technology Inc. (NASDAQ:STI) shares fell 68.4% to $0.6078.
    • DermTech, Inc. (NASDAQ:DMTK) fell 58.4% to $0.1383 after the company filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
    • Interactive Strength Inc. (NASDAQ:TRNR) shares fell 38.9% to $3.00 after surging 71% on Monday.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) shares fell 37% to $2.10. Aerwins Technologies named Kiran Sidhu as the company's interim CFO, following resignation of Yinshun He as CFO on June 11. On June 14, the company received final delisting notice from Nasdaq Hearings Panel of Nasdaq Stock Market.
    • Taysha Gene Therapies Inc (NASDAQ:TSHA) shares fell 34.5% to $2.64 after the company announced longer-term clinical data from the ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from the REVEAL Phase 1/2 pediatric trial of TSHA-102 in Rett syndrome.
    • Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) dipped 32.7% to $5.64 after the FDA placed a partial clinical hold on ZN-c3-001, DENALI, and TETON monotherapy studies of Azenosertib following two recent deaths due to presumed sepsis in the DENALI study.
    • Kaival Brands Innovations Group Inc (NASDAQ:KAVL) declined 29% to $2.97
    • Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) shares fell 28.6% to $4.00 after gaining 60% on Monday.
    • Alarum Technologies Ltd – ADR (NASDAQ:ALAR) fell 27.3% to $25.11.
    • Azitra Inc (NYSE:AZTR) dipped 26.2% to $0.16.
    • Autonomix Medical Inc (NASDAQ:AMIX) shares declined 26% to $1.02 as the company announced preliminary results from first five patients in PoC trial for pancreatic cancer pain.
    • Haoxi Health Technology Ltd (NASDAQ:HAO) dipped 19.4% to $4.62.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares declined 18.6% to $0.62 after jumping over 10% on Monday.
    • Cabaletta Bio Inc (NASDAQ:CABA) shares fell 15.3% to $7.93.
    • Neurogene Inc (NASDAQ:NGNE) dipped 15.3% to $33.88. The company announced that the first patient in Cohort 2 received high-dose NGN-401 gene therapy in the Phase 1/2 trial for female pediatric patients with Rett syndrome.
    • Polestar Automotive Holding Uk Plc (NASDAQ:PSNY) fell 15% to $0.72. Polestar Automotive recently announced geographic expansion and plans to enter seven new markets during 2025.
    • Earlyworks Co Ltd – ADR (NASDAQ:ELWS) shares declined 13% to $1.70. Earlyworks regained compliance with Nasdaq Minimum Bid Price Requirement.
    • SRIVARU Holding Limited (NASDAQ:SVMH) shares fell 12.3% to $0.21.
    • Skye Bioscience Inc (NASDAQ:SKYE) dipped 12.3% to $9.52. Cantor Fitzgerald analyst Kristen Kluska reiterated Skye Bioscience with an Overweight and maintained a $14 price target.
    • CureVac BV (NASDAQ:CVAC) declined 9.4% to $3.15.
    • Novavax Inc (NASDAQ:NVAX) fell 6.2% to $13.18.
    • Geron Corp (NASDAQ:GERN) declined 5.4% to $4.42.

    Now Read This: Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday

    Get the next $ALAR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ALAR
    $AMIX
    $ASNS
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Neurogene Inc.
    $NGNE
    6/17/2025$50.00Buy
    Craig Hallum
    Novavax Inc.
    $NVAX
    6/17/2025$6.00Sell
    Citigroup
    CureVac N.V.
    $CVAC
    6/13/2025$5.00Buy → Hold
    Jefferies
    Chewy Inc.
    $CHWY
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    Chewy Inc.
    $CHWY
    6/5/2025$43.00Buy → Hold
    Jefferies
    Toast Inc.
    $TOST
    6/2/2025$48.00Buy
    Truist
    Neurogene Inc.
    $NGNE
    5/16/2025$24.00Outperform → Neutral
    Robert W. Baird
    Geron Corporation
    $GERN
    5/8/2025$1.50Sector Outperform → Sector Perform
    Scotiabank
    More analyst ratings

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Craig Hallum initiated coverage on Neurogene with a new price target

      Craig Hallum initiated coverage of Neurogene with a rating of Buy and set a new price target of $50.00

      6/17/25 8:10:28 AM ET
      $NGNE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Citigroup initiated coverage on Novavax with a new price target

      Citigroup initiated coverage of Novavax with a rating of Sell and set a new price target of $6.00

      6/17/25 7:50:20 AM ET
      $NVAX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • CureVac downgraded by Jefferies with a new price target

      Jefferies downgraded CureVac from Buy to Hold and set a new price target of $5.00

      6/13/25 7:46:06 AM ET
      $CVAC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Rodgers Richard J

      4 - NOVAVAX INC (0001000694) (Issuer)

      6/24/25 6:40:56 PM ET
      $NVAX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director Mott David M

      4 - NOVAVAX INC (0001000694) (Issuer)

      6/24/25 6:40:20 PM ET
      $NVAX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 4 filed by Director King Rachel K.

      4 - NOVAVAX INC (0001000694) (Issuer)

      6/24/25 6:39:07 PM ET
      $NVAX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rocket Lab Executes Responsive Reschedule of Electron Manifest to Launch Next Mission in Two Days' Time

      Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced a swift turnaround in Electron's launch manifest to fly the next mission in a multi-launch contract for geospatial analytics company HawkEye 360. The mission will fly from Rocket Lab Launch Complex 1 in just two days' time. The mission, named ‘Get The Hawk Outta Here', is scheduled to launch no earlier than Thursday, June 26th UTC from Rocket Lab Launch Complex 1 in New Zealand, ahead of a previous Electron mission that has been rescheduled to allow for additional checkouts. This unprecedented announcement-to-launch timeline underscores Rocket Lab's r

      6/24/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Actelis Secures Order from Major US Telecommunications Carrier for Next-Generation Rapid MDU Connectivity Solutions

      FREMONT, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced it has received an initial order from a major telecommunications carrier in the United States to deploy its advanced GigaLine solutions, allowing instant gigabit connectivity for multi-dwelling unit (MDU). This marks Actelis' first success with a significant telecommunications carrier of this size and stature in the United States, providing the carrier with the Company's innovative GigaLine 800 and GigaLine 900 solutions. These products are specifica

      6/24/25 9:00:00 AM ET
      $ASNS
      Telecommunications Equipment
      Telecommunications
    • Chewy, Inc. Announces Pricing of Upsized Offering of Class A Common Stock by Selling Stockholder and Concurrent Repurchase

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today the pricing of an upsized underwritten public offering of 23,952,096 shares of its Class A common stock, par value $0.01 per share, by Buddy Chester Sub LLC (the "Selling Stockholder"), which is an entity affiliated with funds advised by BC Partners PE, LP ("BC Partners"), Chewy's largest shareholder, at a price to the public of $41.95 per share (the "Offering"). The Selling Stockholder granted the underwriter a 30-day option to purchase up to an additional 3,592,815 shares of Class A common stock. Chewy will not sell any shares of its Class A common stock in the Offering and wi

      6/23/25 9:40:00 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Manning Paul B bought $2,062,500 worth of shares (750,000 units at $2.75) (SEC Form 4)

      4 - Taysha Gene Therapies, Inc. (0001806310) (Issuer)

      6/3/25 9:38:27 PM ET
      $TSHA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Director Lawlis V Bryan bought $15,667 worth of shares (13,300 units at $1.18) (SEC Form 4)

      4 - GERON CORP (0000886744) (Issuer)

      5/13/25 4:20:43 PM ET
      $GERN
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Myers Scott Dunseth bought $29,373 worth of shares (21,000 units at $1.40), increasing direct ownership by 8% to 281,192 units (SEC Form 4)

      4 - Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)

      4/30/25 5:07:20 PM ET
      $ZNTL
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    SEC Filings

    See more
    • Reliance Global Group Inc. filed SEC Form 8-K: Financial Statements and Exhibits

      8-K - Reliance Global Group, Inc. (0001812727) (Filer)

      6/24/25 5:28:11 PM ET
      $RELI
      Specialty Insurers
      Finance
    • Reliance Global Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Reliance Global Group, Inc. (0001812727) (Filer)

      6/24/25 5:22:48 PM ET
      $RELI
      Specialty Insurers
      Finance
    • SEC Form 6-K filed by CureVac N.V.

      6-K - CureVac N.V. (0001809122) (Filer)

      6/24/25 4:50:33 PM ET
      $CVAC
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

      For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

      9/3/24 2:26:49 PM ET
      $NVAX
      $PFE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

      For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

      8/30/24 2:26:48 PM ET
      $NVAX
      $PFE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • June 7, 2024 - FDA Roundup: June 7, 2024

      For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

      6/7/24 3:46:22 PM ET
      $GERN
      $SRAX
      $SNAP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Advertising
      Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Leadership Updates

    Live Leadership Updates

    See more
    • Actelis Networks Accelerates US Federal Government and Military Expansion Efforts, Hires Industry Veteran Sales Director as Company accelerates efforts in Major Military Branches

      FREMONT, Calif, June 16, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that it is accelerating its federal and military market expansion initiatives. As part of this strategic push, the Company is pleased to announce that it has hired Mr. Jason Chasse as full-time Director of Federal Sales. Actelis has a long history serving as a trusted partner to major military and federal agencies and believes the Company is uniquely positioned to capitalize on major opportunities in the sector. These strategic steps reflect Actelis'

      6/16/25 8:15:00 AM ET
      $ASNS
      Telecommunications Equipment
      Telecommunications
    • e.l.f. Revs Up Support for Katherine Legge at NASCAR's Coca-Cola 600 Weekend

      The brand is making power moves towards its commitment to Empower.Legendary.Females. e.l.f. Cosmetics, a brand from e.l.f. Beauty (NYSE:ELF), is speeding into NASCAR's Coca-Cola 600 this weekend with a jumbo-sized activation in celebration of its partnership with professional race car driver Katherine Legge. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250521636169/en/e.l.f. is speeding into NASCAR's Coca-Cola 600 this weekend with Power Grip Garage, a jumbo-sized activation in celebration of its partnership with professional race car driver Katherine Legge. With this immersive, larger-than-life experience showcasing the Jumbo

      5/22/25 12:01:00 AM ET
      $ELF
      Package Goods/Cosmetics
      Consumer Discretionary
    • Stagwell (STGW) Drafts New Picks for SPORT BEACH 2025: Lauren Betts, Myles Garrett, Billie Jean King, Ilona Maher, Brandon Marshall, Katie McCabe, Alex Morgan, Oscar Piastri, Gerard Piqué, Nigel Sylvester, Ian Wright OBE and More Confirmed to Attend

      NEW YORK, May 13, 2025 /PRNewswire/ -- Stagwell (NASDAQ:STGW), the challenger network built to transform marketing, today announced an expanded roster of SPORT BEACH 2025 partners as well as an early look at programming for June 16-19, 2025 at the Cannes Lions International Festival of Creativity. New additions to this year's lineup include college basketball player Lauren Betts, NFL's Myles Garrett, tennis legend Billie Jean King, rugby star Ilona Maher, former NFL player Brandon Marshall, Arsenal & Republic of Ireland footballer Katie McCabe, 2x World Cup Champion Alex Morga

      5/13/25 9:01:00 AM ET
      $DV
      $ELF
      $NWS
      $STGW
      Computer Software: Programming Data Processing
      Technology
      Package Goods/Cosmetics
      Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Financials

    Live finance-specific insights

    See more
    • Quantum to Release Fiscal Fourth Quarter and Full Year 2025 Financial Results on Monday, June 30, 2025

      Quantum® Corporation (NASDAQ:QMCO) ("Quantum" or the "Company") today announced it will release financial results for its fiscal fourth quarter and full year 2025 on Monday, June 30, 2025, after the markets close. Newly appointed Chief Executive Officer, Hugues Meyrath, and Chief Financial Officer, Lewis Moorehead, will host a Business Update conference call and review of the Company's fiscal 2025 financial results on Thursday, July 3, 2025 at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). Analysts and investors are invited to join the conference call using the following information: Conference Call Date: Thursday, July 3, 2025 Time: 8:30 a.m. ET (5:30 a.m. PT) Conference Call Numbe

      6/18/25 8:00:00 AM ET
      $QMCO
      Electronic Components
      Technology
    • La-Z-Boy Incorporated Reports Strong Fourth Quarter and Full Year Results; Sales Growth Across All Segments for the Year and Strong Operating Cash Flow Performance

      Fiscal 2025 Fourth Quarter Highlights: Consolidated delivered sales of $571 million Up 3% versus prior year Retail segment delivered sales increased 8% Company-owned La-Z-Boy Furniture Galleries® network grew by a total of six stores; 203 company-owned store base now represents 55% of total network Wholesale segment delivered sales increased 2%GAAP operating margin of 5.2%; adjusted(1) operating margin of 9.4%, flat versus the year ago periodGAAP diluted EPS of $0.36 and adjusted(1) diluted EPS of $0.92, both of which include a $0.10 impact from unfavorable foreign tax discrete itemsDelivered sales exceeded high end of guidance range and adjusted(1) operating margin at high end of guidance

      6/17/25 4:15:00 PM ET
      $LZB
      Home Furnishings
      Consumer Discretionary
    • Chewy Announces First Quarter 2025 Financial Results

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fiscal year 2025 ended May 4, 2025. Fiscal Q1 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.6 percent decreased 10 basis points year over year Net income of $62.4 million, including share-based compensation expense and related taxes of $78.0 million Net margin of 2.0 percent decreased 30 basis points year over year Basic earnings per share of $0.15, consistent year over year Diluted earnings per share of $0.15, consistent year over year Adjusted EBITDA(1) of $

      6/11/25 7:05:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $ALAR
    $AMIX
    $ASNS
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

      SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

      12/12/24 7:22:30 PM ET
      $KAVL
      Other Consumer Services
      Consumer Discretionary
    • SEC Form SC 13G filed by Neurogene Inc.

      SC 13G - Neurogene Inc. (0001404644) (Subject)

      12/11/24 4:05:09 PM ET
      $NGNE
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

      SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

      12/6/24 4:05:57 PM ET
      $CABA
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care